Bioorganic and Medicinal Chemistry Letters p. 2403 - 2408 (1997)
Update date:2022-09-26
Topics:
Belliotti, Thomas R.
Kesten, Suzanne R.
Rubin, John R.
Wustrow, David J.
Georgic, Lynn M.
Zoski, Kim T.
Akunne, Hyacinth C.
Wise, Lawrence D.
The dopamine D3 receptor is an attractive target for the treatment of schizophrenia. We identified PD137557 (V) as a ligand for the D2 receptor and desired to prepare a selective D3 compound. SAR studies involving different amides and different phenyl piperazines have led to the discovery of 8a and 8c as selective D3 receptor ligands.
View MoreQingdao Kylin Trading Co., Ltd.
Contact:0086-532-68979884/58972912/68972263/65/88171519
Address:Room 2308,A building International Trade Center No.230 Changjiang Middle Road of Qingdao Economic Development Zone,Shandong,China.
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
LIAOYANG WANRONG CHEMICALS COMPANY LIMITED
Contact:86-419-2390789
Address:XINLI VILLAGE , DONG NINGWEI COUNTY,TAIZIHE DISTRICT, LIAOYANG , LIAONING
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Jinan Jinguilin Chemical Co.,Ltd
Contact:+86-531-81188412
Address:3rd floor of Torch Building, Huanyuan Rd, City of Jinan
Doi:10.1002/ejoc.200900407
(2009)Doi:10.14233/ajchem.2013.13227
(2013)Doi:10.1016/j.bmcl.2004.07.001
(2004)Doi:10.1016/S0040-4039(00)94492-7
(1990)Doi:10.1016/S0040-4020(97)10292-7
(1998)Doi:10.1016/S0957-4166(97)00499-0
(1997)
